Loading organizations...
Valquest Partners is a private investment firm specializing in sourcing, shaping, and scaling venture capital and private equity. The firm targets high-quality, long-life assets across Energy, Power, MedTech, and Industrial Biotech. Its portfolio spans Europe and the GCC, leveraging deep industry knowledge.
Fadi Noureddine and Walid Sfeir co-founded the firm in 2013 as managing partners. Noureddine brings M&A and energy investing expertise from Morgan Stanley. Sfeir's background at McKinsey & Company provides strategic and operational leadership across industrial sectors, shaping their investment approach.
Valquest Partners collaborates with promising companies, providing capital and strategic oversight for growth. The firm’s vision is to be a premier independent investor and manager, creating enduring value via rigorous asset selection and active portfolio management. It aims for sustainable returns by backing companies poised for long-term impact.
ValQuest Partners has 1 tracked investment across 1 company. The latest tracked deal is $42.9M Series B in TISSIUM in November 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 20, 2019 | TISSIUM | $42.9M Series B | — | BNP Paribas Développement, Bpifrance, Credit Mutuel Innovation, European Investment Fund, Karista, M&L Investments, Omnes Capital, Sofinnova Partners |
